Selective Inhibition of Bruton?S Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors

AuthID
 P-00X-H6X
23
Author(s)
De Almeida, CR
·
Lopes, R
·
Martins Logrado, A
·
Neves, V
·
[+2]·
[+1]·
Vladimer, GI
·
Krall, N
·
Joao, C
·
View all authors
Document Type
Article
Year published
2022
Published
in ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE
Volume: 5, Issue: 11, Pages: 1156-1168 (13)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 36407952
Scopus: 2-s2.0-85141952162
Wos: WOS:000914730600001
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Sousa, BB;   2 De Almeida, CR;   3 Barahona, AF;
4 Lopes, R;   5 Martins Logrado, A;   6 Cavaco, M;
7 Neves, V;   8 Carvalho, LAR;   9 Labao Almeida, C;
10 Coelho, AR;   11 Bento, ML;   12 Lopes, RMRM;
13 Oliveira, BL;   14 Castanho, MARB;   15 Neumeister, P;
16 Deutsch, A;   17 Vladimer, GI;   18 Krall, N;
19 Joao, C;   20 Corzana, F;   21 Seixas, JD;
22 Fior, R;   23 Bernardes, GJL;  

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service